Nacimbio Demonstrates Achievements at the "Import Substitution" Exhibition

Nacimbio Demonstrates Achievements at the "Import Substitution" Exhibition


National Immunobiological Company participates in the International Specialized Exhibition "Import Substitution". The holding company demonstrates immunobiological preparations and pharmaceutical products manufactured in Russia at the exhibition stand of the Rostec State Corporation.

The company exhibits the best-in-class immunobiological preparations for influenza prevention, "Sovigripp" and "Ultrix", bacteriophages and botulinum toxin "Relatox".

It should be recalled that since 2015 the holding company has been the supplier of Russian vaccines included in the National Vaccine Calendar for the state-owned medical institutions. In the period of 2015-2017 the share of the Russian products in the vaccines procurement volumes has increased in monetary terms from 31% to 57%, respectively.

"Support to pharmaceutical manufacturers as part of the state policy for import substitution is of great importance for the industry. Due to the efforts taken, during the recent years the reliance of the Russian healthcare system on imported medications was significantly reduced", comments the General Director of National Immunobiological Company Andrey Zagorsky.

The annual exhibition "Import Subsitution" is being held from 12 to 14 September in Moscow and demonstrates the successes of the Russian companies in development of owned production capacities for output of competitive import-substituting goods and services.